Home › Funds › Ranger Investment Management, L.P. › CRL
Ranger Investment Management, L.P. position in CRL
CHARLES RIV LABS INTL INC · Health Care
Ranger Investment Management, L.P. reported holding 45,887 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$13.5M, representing 1.27% of its reported portfolio and ranking #29 among its reported holdings. Ranger Investment Management, L.P. has disclosed CRL holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Ranger Investment Management, L.P.'s CRL position evolved
Ranger Investment Management, L.P. first disclosed a stake in CRL in Q3 2023 at 26 shares (US$5K). The position peaked in Q2 2026 at 66,182 shares, worth US$15.0M. Across 8 filings, Ranger Investment Management, L.P. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 45,887 shares valued at US$13.5M — a reduction of -20,295 shares quarter over quarter.. Notable position changes include a 62% increase in Q1 2024 (shares fell 24% over the following quarter), a 55% trim in Q3 2024 (shares fell 6% over the following quarter), a 31% trim in Q3 2026 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 26 | $5.09K | New |
| Q4 2023 | 26 | $6.15K | Hold |
| Q1 2024 | 42 | $11.38K | Add |
| Q2 2024 | 42 | $8.68K | Hold |
| Q3 2024 | 19 | $3.74K | Reduce |
| Q1 2026 | 70.72K | $12.20M | New |
| Q2 2026 | 66.18K | $15.01M | Reduce |
| Q3 2026 | 45.89K | $13.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M sh · $320.67M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K sh · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on Ranger Investment Management, L.P.
FAQ
How long has Ranger Investment Management, L.P. held CRL?
Ranger Investment Management, L.P. has disclosed CRL holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is Ranger Investment Management, L.P.'s current position in CRL?
As of Q3 2026, Ranger Investment Management, L.P. holds 45.89K shares of CRL (CHARLES RIV LABS INTL INC), valued at $13.54M, representing 1.27% of its reported portfolio and ranking #29.
Has Ranger Investment Management, L.P. been buying or selling CRL?
In the latest 13F filing (Q3 2026), Ranger Investment Management, L.P. reduced its position in CRL. The position peaked in Q2 2026 at 66.18K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.